Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation

Thromboembolic complications are a leading cause of morbidity and mortality in cancer patients. Cancer patients often present with an increased risk for thrombosis including hypercoagulation, so the application of antiplatelet strategies to oncology warrants further investigation. This study investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xulu, Kutlwano R., Augustine, Tanya N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074114/
https://www.ncbi.nlm.nih.gov/pubmed/33923802
http://dx.doi.org/10.3390/ijms22084153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074114/
https://www.ncbi.nlm.nih.gov/pubmed/33923802
http://dx.doi.org/10.3390/ijms22084153

Ejemplares similares